Ralf Lotz
Boehringer Ingelheim (India)(IN)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, Pharmacological Effects and Assays, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes(2007)282 cited
- → Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)(2009)230 cited
- → Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib(2019)191 cited
- → Structure elucidation of yersiniabactin, a siderophore from highly virulent Yersinia strains(1995)119 cited
- → Discovery of olodaterol, a novel inhaled β2-adrenoceptor agonist with a 24 h bronchodilatory efficacy(2010)80 cited
- → Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule(2019)64 cited
- → Determination of naphthodianthrones in plant extracts from Hypericum perforatum L. by liquid chromatography–electrospray mass spectrometry(1997)61 cited
- Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance.(1997)
- → 3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors(2008)40 cited
- → Muscle to Brain Partitioning as Measure of Transporter-Mediated Efflux at the Rat Blood–Brain Barrier and Its Implementation into Compound Optimization in Drug Discovery(2019)17 cited